BioSpace News Archive

Drug Development

Gannex Announces Completion of the U.S. Phase I Trial of ASC43F, an In-House Developed First-in-Class Dual Targeting Fixed-dose Combination Tablet for NASH

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), today announces the completion of the U.S. Phase I trial of ASC43F, an in-house developed, first-in-class dual targeting fixed-dose combination (FDC) tablet for non-alcoholic steatohepatitis (NASH).

January 3, 2022
·
5 min read
Business

GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune Private Limited in India

GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they have entered into an exclusive licensing agreement, pursuant to which Rivaara Immune has agreed to develop and commercialize Immuncell-LC® in India, Sri Lanka, and Bangladeshi.

January 3, 2022
·
3 min read
Drug Development

Stuart Therapeutics, Inc. Announces Successful Phase 2 Clinical Trial Results of its Novel Dry Eye Candidate ST-100

Stuart Therapeutics, Inc. (STUART), a clinical stage, innovative ophthalmic therapeutic development company, today announced the topline results of the first in human Phase 2 clinical trial for its lead drug candidate, ST-100 in patients with dry eye disease.

January 3, 2022
·
5 min read
Pharm Country

Cara Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Cara Therapeutics, Inc. announced that Christopher Posner, President and Chief Executive Officer, will present a company overview at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 11:15 a.m. ET.

January 3, 2022
·
1 min read
Genetown

iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference

iTeos Therapeutics, Inc. announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Conference being held virtually on Tuesday, January 11, 2022 at 11:15 a.m. ET.

January 3, 2022
·
2 min read
Kiniksa Pharmaceuticals to Present at 40th Annual J.P. Morgan Healthcare Conference

Kiniksa Pharmaceuticals, Ltd. announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 1:30 p.m. Eastern Time.

January 3, 2022
·
1 min read
Biotech Beach

Neurocrine Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

Neurocrine Biosciences, Inc. will present at the virtual 40th Annual J.P. Morgan Healthcare Conference at 11:15 a.m. Eastern Time on Monday Jan. 10, 2022.

January 3, 2022
·
1 min read
Business

CONMED Corporation to Announce Fourth Quarter 2021 Financial Results on January 26, 2022

CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the fourth quarter 2021 after the market close on Wednesday, January 26, 2022.

January 3, 2022
·
2 min read
Business

John Varian Joins Acorda Therapeutics Board of Directors

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that John Varian has joined its board of directors, effective January 1, 2022.

January 3, 2022
·
5 min read
Business

Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’s Board of Directors

Enzo Biochem, Inc., a leading biosciences and diagnostics company, announced the appointments of Hamid Erfanian and Bradley Radoff to the Company’s Board of Directors, effective immediately.

January 3, 2022
·
4 min read